Rekah Pharmaceutical Industry Ltd (REKA) — Strategic Asset Allocation Index
Rekah Pharmaceutical Industry Ltd (REKA) has a Strategic Asset Allocation Index of 94.8% as of June 2023. Strategic assets (PP&E of ILA153.37 Million plus long-term investments of ILA-) total ILA153.37 Million, measured against net assets of ILA161.84 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Rekah Pharmaceutical Industry Ltd Strategic Asset Allocation Index (2004–2021)
This chart shows how Rekah Pharmaceutical Industry Ltd's Strategic Asset Allocation Index has evolved across 18 annual periods from 2004 to 2021. As of June 2023, the index stands at 94.8%, representing strategic assets of ILA153.37 Million against net assets of ILA161.84 Million ILA. Explore cash efficiency ratio of Rekah Pharmaceutical Industry Ltd to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Rekah Pharmaceutical Industry Ltd (2004–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Rekah Pharmaceutical Industry Ltd from 2004 to 2021, covering 18 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see REKA market cap.
| Year | SAAI | Strategic Assets (ILA) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 102.3% | ILA177.00 Million | ILA177.00 Million | ILA- | ILA173.06 Million | ▼ -7.5 pp |
| 2020 | 109.8% | ILA181.82 Million | ILA181.82 Million | ILA- | ILA165.59 Million | ▼ -6.8 pp |
| 2019 | 116.6% | ILA181.02 Million | ILA181.02 Million | ILA- | ILA155.22 Million | ▲ +52.0 pp |
| 2018 | 64.7% | ILA97.43 Million | ILA97.43 Million | ILA- | ILA150.66 Million | ▼ -1.9 pp |
| 2017 | 66.6% | ILA96.28 Million | ILA96.28 Million | ILA- | ILA144.62 Million | ▼ -17.1 pp |
| 2016 | 83.7% | ILA88.56 Million | ILA88.56 Million | ILA- | ILA105.86 Million | ▲ +13.3 pp |
| 2015 | 70.4% | ILA87.01 Million | ILA86.40 Million | ILA610.00K | ILA123.66 Million | ▼ -36.1 pp |
| 2014 | 106.5% | ILA82.05 Million | ILA82.05 Million | ILA- | ILA77.06 Million | ▲ +18.6 pp |
| 2013 | 87.9% | ILA69.89 Million | ILA69.89 Million | ILA- | ILA79.51 Million | ▼ -13.7 pp |
| 2012 | 101.6% | ILA72.30 Million | ILA72.30 Million | ILA- | ILA71.17 Million | ▼ -5.9 pp |
| 2011 | 107.5% | ILA68.82 Million | ILA68.82 Million | ILA- | ILA64.00 Million | ▲ +0.4 pp |
| 2010 | 107.1% | ILA68.31 Million | ILA68.31 Million | ILA- | ILA63.78 Million | ▲ +3.1 pp |
| 2009 | 104.0% | ILA66.74 Million | ILA66.74 Million | ILA- | ILA64.15 Million | ▼ -0.8 pp |
| 2008 | 104.9% | ILA61.48 Million | ILA61.48 Million | ILA- | ILA58.62 Million | ▲ +21.1 pp |
| 2007 | 83.8% | ILA56.24 Million | ILA56.24 Million | ILA- | ILA67.10 Million | ▼ -10.5 pp |
| 2006 | 94.3% | ILA58.03 Million | ILA58.03 Million | ILA- | ILA61.54 Million | ▲ +18.5 pp |
| 2005 | 75.8% | ILA44.62 Million | ILA44.62 Million | ILA- | ILA58.85 Million | ▼ -12.2 pp |
| 2004 | 88.1% | ILA43.03 Million | ILA43.03 Million | ILA- | ILA48.86 Million | — |